Chunling Lu, PhD1, Catherine Michaud1, and Christopher Murray, MD, PhD2. (1) Global Health Initiative, Harvard University, 104 Mt. Auburn Street, Cambridge, MA, MA 02138, 617-495-4866, email@example.com, (2) Harvard Initiative for Global Health, 104 Mount Auburn Street, 3rd Floor, Cambridge, MA 02139
The Global Fund was created to finance a dramatic turn-around in the fight against AIDS, tuberculosis (TB), and malaria in 2002. It is the primary financing instrument for the global fight against TB, accounting for two-thirds of annual international expenditure to curb the disease. This study investigates the relationship between the expenditure of the Global Fund on fighting against TB and the prevalence and treatment of this disease across countries. The data is obtained from the Global Fund which has publicly available information on the commitments and disbursements for TB projects in the Global Fund. The information on prevalence and coverage (people who are treated) of TB across countries and years is from the WHO website. We examine the coverage variation across countries and over time. Using the ordinary least square model with random effects analysis, we also explore the determinants of the level of coverage by looking at attributes of the government and country, such as GDP level, national spending on health, political stability, and control of corruption. The information of government attributes and country attributes is obtained from the World Bank. The preliminary results show that countries with a low level of GDP and low health spending as a percentage of GDP have a bigger jump in the coverage after the Global Fund started the program in these countries.
Learning Objectives: At the conclusion of the session, the participant in this session will be able to
Presenting author's disclosure statement:
Any relevant financial relationships? No
The 134th Annual Meeting & Exposition (November 4-8, 2006) of APHA